ArticleMikrochimica acta2026
Efficient fabrication of paper-based microfluidic biosensors incorporating laser-induced graphene for label-free electrochemical immunoassays.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nano-Enabled Microfluidic Platforms for Functional Immunomonitoring in Pediatric Sepsis.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To improve the performance in electrochemical immunoassays, paper-based devices typically necessitate the introduction of transducing materials through additional preparation steps, and the assay procedures often require labeling steps. Here we show that laser fabrication can generate both transducing and microfluidic components of paper-based devices to support label-free immunoassays. Laser parameters were adjusted to improve the electrochemical properties of paper-based graphenic transducing structures. Surface treatment for label-free biosensing was performed, and the device configuration and operation for electrochemical impedance spectroscopy sensing were explored. Interleukin-6 protein was used as a representative target to evaluate the analytical performance of the developed immunosensors. In phosphate buffered saline, the immunosensors exhibited a sensitivity of 67.95 Ω/decade and a limit of detection of 4.66 pg/mL. In artificial serum, the immunosensors exhibited a sensitivity of 57.08 Ω/decade and a limit of detection of 5.35 pg/mL. The clinical application potential was further demonstrated with human serum samples. The presented approach for developing paper-based microfluidic immunosensors can enhance their performance while maintaining ease of fabrication and usage to meet different requirements in clinical practice.
Indexed as
Identifiers
42728508What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.